Is Autonomix Medical, Inc. Common Stock a good investment? Autonomix Medical, Inc. Common Stock (AMIX) is currently trading at 1.61 USD. Market analysts have a consensus price target of 40.80 USD. This suggests a potential upside from current levels.
Earnings Schedule: Autonomix Medical, Inc. Common Stock is expected to release its next earnings report on Nov. 11, 2026. The market consensus estimate for Forward EPS is -7.40.
No, it does not currently pay a dividend.
Autonomix Medical, Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Nov. 11, 2026. The company currently has a trailing EPS of -39.67.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
| Split Date | Split Ratio to 1 |
|---|---|
| Oct. 25, 2024 | 1:20 |
| June 24, 2026 | 1:21 |
Community Discussion